ART and CVD: Bringing Science to Practice
hosted byPrime Education, LLCART and CVD: Bringing Science to Practice is organized by Prime Education, LLC.
Release Date: September 27, 2023
Expiration Date: September 26, 2024
Description:
People living with HIV (PWH) are living longer with advances in antiretroviral therapy (ART); therefore, clinicians are now in the position of managing HIV-associated comorbidities, such as cardiovascular disease (CVD), along with viral management. Test your knowledge on the application of new clinical evidence for managing patients' ART with new or pre-existing CVD in this bite-size interactive quiz!
For information on how this activity fits in the Royal College of Physicians and Surgeons of Canada Maintenance of Certification (MOC) Program, please visit the Royal College's website(opens in a new tab). For more personalized support, please contact the Royal College Services Center (1-800-461-9598) or your local CPD Educator.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found here(opens in a new tab).
International learners are encouraged to consult with their local boards and/or agencies for equivalency status.
Learning Objectives:
• Apply recent guideline updates as well as clinical trials and real-world evidence in the development of individualized HIV prevention plans
• Compare the safety, efficacy, and pharmacologic profiles of antiretroviral agents with novel mechanisms of action and routes of administration
• Integrate the latest data and expert best practices to tailor PrEP selection for diverse patients facing unique challenges such as comorbid conditions, multidrug resistance, and factors impeding adherence
